AIDS Vaccines

Merck Pledges Aggressive Development of HIV DNA Vaccine

Published in AIDS Weekly, June 23rd, 1997

A major U.S. pharmaceutical company has promised a full-scale effort to develop an HIV vaccine.

The promise came from R. Gordon Douglas, president of Merck Vaccines, Merck & Co. Inc., in a briefing on AIDS vaccines delivered to the Congressional Task Force on International HIV/AIDS.

Merck has licensed naked DNA technology from Vical Inc., San Diego, California, for use in developing vaccines for HIV and six other pathogens (hepatitis B, hepatitis C, herpes simplex, human papilloma virus, influenza, and tuberculosis).

"Merck has already invested thousands of research hours and millions of dollars toward the discovery, development,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-06-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry